Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
mevrometostat (PF-06821497)
i
Other names:
PF-06821497, PF 06821497 , PF06821497
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Pfizer
Drug class:
EZH2 inhibitor
Related drugs:
‹
tazemetostat (17)
GSK2816126 (5)
CPI-169 (3)
valemetostat (3)
SHR-2554 (3)
DZR123 (3)
JQEZ5 (2)
DW91170 (1)
HM97594 (1)
UNC1999 (1)
EPZ005687 (0)
EPZ011989 (0)
EZH2 inhibitor (0)
GSK343 (0)
HH2853 (0)
HM97662 (0)
OR-S1 (0)
XNW5004 (0)
CPI-1205 (0)
tazemetostat (17)
GSK2816126 (5)
CPI-169 (3)
valemetostat (3)
SHR-2554 (3)
DZR123 (3)
JQEZ5 (2)
DW91170 (1)
HM97594 (1)
UNC1999 (1)
EPZ005687 (0)
EPZ011989 (0)
EZH2 inhibitor (0)
GSK343 (0)
HH2853 (0)
HM97662 (0)
OR-S1 (0)
XNW5004 (0)
CPI-1205 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login